To sum up, these results further demonstrated that NRPP can inhibit xenograft tumour growth via p53/BNIP3/NIX pathway‐mediated mitophagy initiation in MDA‐MB‐435S breast cancer xenograft models. The gene discussed is BNIP3L; the disease is breast carcinoma.